Clodi, Martin; Abrahamian, Heidemarie; Brath, Helmut; Brix, Johanna; Drexel, Heinz; Fasching, Peter; Föger, Bernhard; Francesconi, Claudia; Fröhlich-Reiterer, Elke; Harreiter, Jürgen; Hofer, Sabine E; Hoppichler, Friedrich; Huber, Joakim; Kaser, Susanne; Kautzky-Willer, Alexandra; Lechleitner, Monika; Ludvik, Bernhard; Luger, Anton; Mader, Julia K; Paulweber, Bernhard; ... (2019). [Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2019)]. Wiener klinische Wochenschrift, 131(Suppl 1), pp. 27-38. Springer-Verlag 10.1007/s00508-019-1471-z
|
Text
ClodiM_AntihyperglykämischeTherapie_WienKlinWochenschr.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (511kB) | Preview |
Hyperglycemia significantly contributes to complications in patients with diabetes mellitus. While lifestyle interventions remain cornerstones of disease prevention and treatment, most patients with type 2 diabetes will eventually require pharmacotherapy for glycemic control. The definition of individual targets regarding optimal therapeutic efficacy and safety as well as cardiovascular effects is of great importance. In this guideline we present the most current evidence-based best clinical practice data for healthcare professionals.
Item Type: |
Journal Article (Review Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Angiology |
UniBE Contributor: |
Drexel, Heinz |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0043-5325 |
Publisher: |
Springer-Verlag |
Language: |
German |
Submitter: |
Isabel Lorenz |
Date Deposited: |
13 Dec 2019 09:27 |
Last Modified: |
05 Dec 2022 15:33 |
Publisher DOI: |
10.1007/s00508-019-1471-z |
PubMed ID: |
30980148 |
Uncontrolled Keywords: |
Diabetes mellitus Type 2 Glucose lowering Therapy |
BORIS DOI: |
10.7892/boris.136390 |
URI: |
https://boris.unibe.ch/id/eprint/136390 |
Actions (login required)
 |
Edit item |